Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Mar 14, 2005; 11(10): 1445-1451
Published online Mar 14, 2005. doi: 10.3748/wjg.v11.i10.1445
Published online Mar 14, 2005. doi: 10.3748/wjg.v11.i10.1445
Table 2 Expression of syndecan-1 protein categorized by pathological variables.
Variables | Syndecan-1 | P | |
- | + | ||
Serum AFP level | |||
≤25 ng/mL (n = 22) | 8 | 14 | 0.28 |
>25 ng/mL (n = 29) | 15 | 14 | |
HBsAg | |||
Positive (n = 16) | 6 | 10 | 0.465 |
Negative (n = 35) | 17 | 18 | |
Microsatellite nodule | |||
Absent (n = 31) | 13 | 18 | 0.578 |
Present (n = 20) | 10 | 10 | |
Tumor size | |||
≤3 cm (n = 18) | 9 | 9 | 0.607 |
>3 cm (n = 33) | 14 | 19 | |
Cirrhosis | |||
Absent (n = 36) | 17 | 19 | 0.64 |
Present (n = 15) | 6 | 9 | |
Necrosis | |||
Absent (n = 24) | 10 | 14 | 0.646 |
Present (n = 27) | 13 | 14 | |
Portal vein thrombosis | |||
Absent (n = 37) | 15 | 22 | 0.292 |
Present (n = 14) | 8 | 6 | |
Differentiation | |||
Well (n = 35) | 10 | 25 | 0.001 |
Low (n = 16) | 13 | 3 | |
Extra-hepatic metastasis | |||
Absent (n = 41) | 15 | 26 | 0.014 |
Present (n = 10) | 8 | 2 |
- Citation: Li HG, Xie DR, Shen XM, Li HH, Zeng H, Zeng YJ. Clinicopathological significance of expression of paxillin, syndecan-1 and EMMPRIN in hepatocellular carcinoma. World J Gastroenterol 2005; 11(10): 1445-1451
- URL: https://www.wjgnet.com/1007-9327/full/v11/i10/1445.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i10.1445